XCR1 and neoplasm: XCR1 (X-C motif chemokine receptor 1) and XCL1 (X-C motif chemokine ligand 1) had been reported to enhance proliferation of antigen-specific CD8+ T cells and their anti-tumor immunity (66, 67).